NUP107 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.662400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.043000E-01
Normal-vs-Stage2
6.560400E-01
Normal-vs-Stage3
8.707600E-02
Normal-vs-Stage4
6.144000E-01
Stage1-vs-Stage2
2.441600E-01
Stage1-vs-Stage3
7.876100E-03
Stage1-vs-Stage4
4.285400E-01
Stage2-vs-Stage3
1.767360E-01
Stage2-vs-Stage4
7.799800E-01
Stage3-vs-Stage4
8.380100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.433600E-01
Normal-vs-AfricanAmerican
2.258200E-01
Normal-vs-Asian
9.191800E-01
Caucasian-vs-AfricanAmerican
4.559400E-01
Caucasian-vs-Asian
5.785200E-01
AfricanAmerican-vs-Asian
4.603000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.884200E-01
Normal-vs-Female
3.305000E-01
Male-vs-Female
4.503600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.284600E-01
Normal-vs-Age(41-60Yrs)
9.696400E-01
Normal-vs-Age(61-80Yrs)
2.151200E-01
Normal-vs-Age(81-100Yrs)
3.922800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.384800E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.880170E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.606180E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.762200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.900370E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.871200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.037200E-01
Normal-vs-Daily Drinker
1.963570E-01
Normal-vs-Weekly Drinker
4.447000E-01
Normal-vs-Occasional Drinker
7.986400E-01
Normal-vs-Social Drinker
3.186200E-01
Non Drinker-vs-Daily Drinker
9.759000E-01
Non Drinker-vs-Weekly Drinker
5.859000E-01
Non Drinker-vs-Occasional Drinker
1.412160E-01
Non Drinker-vs-Social Drinker
3.011800E-01
Daily Drinker-vs-Weekly Drinker
6.128000E-01
Daily Drinker-vs-Occasional Drinker
1.446580E-01
Daily Drinker-vs-Social Drinker
3.037800E-01
Weekly Drinker-vs-Occasional Drinker
2.174000E-01
Weekly Drinker-vs-Social Drinker
7.720400E-01
Occasional Drinker-vs-Social Drinker
2.415600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.114600E-01
Normal-vs-Grade 2
8.987400E-01
Normal-vs-Grade 3
9.030800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.601500E-02
Grade 1-vs-Grade 3
6.001600E-03
Grade 1-vs-Grade 4
9.114600E-01
Grade 2-vs-Grade 3
4.454600E-01
Grade 2-vs-Grade 4
8.987400E-01
Grade 3-vs-Grade 4
9.030800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.987200E-01
Normal-vs-NonDiabetic
6.326600E-01
Diabetic-vs-NonDiabetic
4.906600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.038200E-01
Normal-vs-NoPancreatitis
6.220000E-01
Pancreatitis-vs-NoPancreatitis
1.059030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.048400E-01
Normal-vs-N1
4.058600E-01
N0-vs-N1
1.189190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.165600E-01
Normal-vs-TP53-NonMutant
2.640000E-01
TP53-Mutant-vs-TP53-NonMutant
1.315960E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
